The study is listed as completed, with Lilly first submitting the record on Sept. 3, 2025, which marked the formal public listing. The latest update on April 23, 2026 signals fresh information, likely ...
Pfizer Inc (PFE) announced an update on their ongoing clinical study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results